These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29768182)

  • 1. Enhanced production and immunological characterization of recombinant West Nile virus envelope domain III protein.
    Tripathi NK; Karothia D; Shrivastava A; Banger S; Kumar JS
    N Biotechnol; 2018 Nov; 46():7-13. PubMed ID: 29768182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.
    Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV
    Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
    Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
    Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P
    Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.
    Tan LC; Chua AJ; Goh LS; Pua SM; Cheong YK; Ng ML
    Protein Expr Purif; 2010 Nov; 74(1):129-37. PubMed ID: 20600950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
    Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.
    Brandler S; Marianneau P; Loth P; Lacôte S; Combredet C; Frenkiel MP; Desprès P; Contamin H; Tangy F
    J Infect Dis; 2012 Jul; 206(2):212-9. PubMed ID: 22551814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
    Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G
    Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and diagnostic application of recombinant domain III of West Nile envelope protein in Brazil.
    Chávez JH; Reis VP; Silva JR; Laure HJ; Rosa JC; Fonseca BA; Figueiredo LT
    Rev Soc Bras Med Trop; 2013; 46(1):97-9. PubMed ID: 23563834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of mice against West Nile virus with recombinant envelope protein.
    Wang T; Anderson JF; Magnarelli LA; Wong SJ; Koski RA; Fikrig E
    J Immunol; 2001 Nov; 167(9):5273-7. PubMed ID: 11673542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.
    Chu JJH; Rajamanonmani R; Li J; Bhuvanakantham R; Lescar J; Ng ML
    J Gen Virol; 2005 Feb; 86(Pt 2):405-412. PubMed ID: 15659760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of an envelope gene of West Nile virus and evaluation of the protein for use in an IgM ELISA.
    Saxena D; Parida M; Rao PV; Kumar JS
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):396-401. PubMed ID: 23357292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
    Alonso-Padilla J; de Oya NJ; Blázquez AB; Escribano-Romero E; Escribano JM; Saiz JC
    Vaccine; 2011 Feb; 29(9):1830-5. PubMed ID: 21211580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and characterization of highly specific recombinant antibodies against West Nile Virus E protein.
    Rizzo S; Imperato P; Mora-Cárdenas E; Konstantinidou S; Marcello A; Sblattero D
    J Biotechnol; 2020 Mar; 311():35-43. PubMed ID: 32061739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.